Loading…
Aarti Drugs (AARTIDRUGS)₹499.75+11.08%Pharmaceuticals
Aarti Drugs is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 24.0 against a peer median of 45.6, and ROCE of 12.1% against a peer median of 14.0%, and latest-quarter sales growth of 18.9% against a peer median of 18.6%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Senores Pharmaceuticals | 5,417 | 40.6 | 15.0 | 13.5 | 0.37 | 0.0 | 632 | 122 | 18.6 | 23.4 | vs AARTIDRUGS |
| Orchid Pharma | 5,291 | 421.0 | 2.0 | 1.3 | 0.28 | 0.0 | 1,229 | 10 | 15.5 | — | vs AARTIDRUGS |
| Supriya Lifescience | 5,082 | 24.3 | 25.1 | 19.1 | 0.00 | 0.2 | 826 | 209 | 50.7 | 48.1 | vs AARTIDRUGS |
| SMS Pharmaceuticals | 4,809 | 46.8 | 13.0 | 14.2 | 0.46 | 0.1 | 886 | 102 | 5.6 | 4.9 | vs AARTIDRUGS |
| Gufic Biosciences | 4,760 | 64.8 | 12.0 | 10.2 | 0.61 | 0.0 | 948 | 64 | 16.6 | 69.1 | vs AARTIDRUGS |
| Aarti Drugs | 4,563 | 24.0 | 12.1 | 13.4 | 0.37 | 0.4 | 2,564 | 194 | 18.9 | −7.5 | — |
| Zota Health Care | 4,410 | — | −8.0 | −15.1 | 0.39 | 0.1 | 539 | −74 | 54.2 | — | vs AARTIDRUGS |
| Evonile Pharma | 4,343 | 44.5 | 16.0 | 11.7 | 0.00 | 0.0 | 353 | 93 | 18.1 | 14.3 | vs AARTIDRUGS |
| RPG Life Sciences | 4,283 | 39.1 | 26.0 | 19.3 | 0.03 | 0.9 | 708 | 115 | 16.4 | −24.3 | vs AARTIDRUGS |
| Gujarat Themis Biosyn | 4,138 | 88.5 | — | — | — | 0.2 | 165 | 47 | 22.3 | 22.5 | vs AARTIDRUGS |
| Kwality Pharmaceuticals | 4,011 | 49.3 | 24.0 | 22.9 | 0.39 | 0.0 | 503 | 67 | 46.0 | 116.4 | vs AARTIDRUGS |
| Peer median | 4,563 | 45.6 | 14.0 | 13.5 | 0.37 | 0.1 | 708 | 93 | 18.6 | 22.5 |
Listed companies closest to Aarti Drugs in Pharmaceuticals include Senores Pharmaceuticals, Orchid Pharma, Supriya Lifescience, SMS Pharmaceuticals, Gufic Biosciences, Zota Health Care, Evonile Pharma, RPG Life Sciences.
Senores Pharmaceuticals, with a market cap of ₹5,417 Cr.
Aarti Drugs trades at a P/E of 24.0; the median of its peer set is 45.6. A P/E above or below the median is a description, not a judgement on value.
Aarti Drugs' return on capital employed is 12.1%, below the peer median of 14.0%.